Skip to main content
. 2014 Oct 15;124(25):3692–3698. doi: 10.1182/blood-2014-08-595496

Table 3.

Interruption patterns, according to treatment assignment, for the 9260 procedures that were included in the analysis

Overall Apixaban Warfarin
Interruption
 No interruption* 3468 (37.5) 1775 (37.9) 1693 (37.0)
 Any interruption 5792 (62.5) 2904 (62.1) 2888 (63.0)
Stop
 Did not stop 3155 (34.1) 1639 (35.0) 1516 (33.1)
 Stopped the day of procedure 313 (3.4) 136 (2.9) 177 (3.9)
 Stopped the day before procedure 365 (3.9) 230 (4.9) 135 (2.9)
 Stopped 2 d before procedure 807 (8.7) 523 (11.2) 284 (6.2)
 Stopped 3 d before procedure 1142 (12.3) 593 (12.7) 549 (12.0)
 Stopped 4 d before procedure 1437 (15.5) 664 (14.2) 773 (16.9)
 Stopped 5 d before procedure 1151 (12.4) 510 (10.9) 641 (14.0)
 Stopped 6 d before procedure 495 (5.3) 217 (4.6) 278 (6.1)
 Stopped 7 d before procedure 395 (4.3) 167 (3.6) 228 (5.0)

Values are frequency (%).

*

Includes no interruption and stopped the day of procedure.